Skip to main content

Together we are beating cancer

Donate now

Cancer Research UK-funded research

Showing 12 out of 983 results
Researcher in a lab

A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment. A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment.

by Cancer Research UK | News | 28 June 2021

28 June 2021

Graphic explaining the IDx trial.

The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable. The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable.

by Harry Jenkins | News | 16 June 2021

16 June 2021

White pills on a pink background

Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery. Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.

by Harry Jenkins | News | 26 May 2021

26 May 2021

Ovarian cancer micrograph

In 1999, Menon joined Professor Ian Jacobs to set up the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 20 years later, the results are in. In 1999, Menon joined Professor Ian Jacobs to set up the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 20 years later, the results are in.

by Katie Roberts | Analysis | 12 May 2021

12 May 2021

Alive (green) and dead (red) myeloma cells under the microscope.

A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’. A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’.

by Eleanor Bennett | Analysis | 29 April 2021

29 April 2021

  • Science & Technology
  • Health & Medicine

Predicting future breast cancer with precision

An international team of Cancer Grand Challenges scientists are conducting one biggest studies of its kind to try to predict who will develop invasive breast cancer. An international team of Cancer Grand Challenges scientists are conducting one biggest studies of its kind to try to predict who will develop invasive breast cancer.

by Alex Lathbridge | Analysis | 22 March 2021

22 March 2021

The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment. The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment.

by Alex Lathbridge | Analysis | 15 March 2021

15 March 2021

A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice

by Alex Lathbridge | Analysis | 15 February 2021

15 February 2021

  • Science & Technology
  • Health & Medicine

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

by Katie Roberts | Analysis | 14 January 2021

14 January 2021

Photo of a scientist working in a lab

COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell. COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell.

by Michelle Mitchell | Opinion | 30 December 2020

30 December 2020